| abstract |
PROBLEM TO BE SOLVED: To provide a stable, more potent and safer nanoplatinate in cancer chemotherapy, which overcomes the drawbacks such as toxicity, low drug release kinetics, low circulatory stability and the like. SOLUTION: For example, a platinum complex compound coordinated with a ligand having a cholesterol site adjusted as shown below and trans-cyclohexanediamine. [Selection diagram] None |